Opthea Limited (NASDAQ: OPTEY) — Healthcare · Share Price, Chart & Market Data
About: Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.05 (-18.61%)
OPTEYOpthea Limited
Loading watchlist status…
Trade OPTEY now
Opthea Limited share price
OPTEY price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:32 am GMT+0
OPTEY price performance
65.254%
5D
28.289%
1M
-14.474%
YTD
-98.57%
1Y
OPTEY price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:32 am GMT+0
OPTEY details
OPTEY Market Signals